ODN-2395

N/A

Report date: 2025/01/26 16:00:35
NME

Base Information

Drug NameODN-2395
Drug Alias NameTLR9 agonist (TriSalus)TLR9 agonist (TriSalus Life Sciences)ODN-2395
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTriSalus Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTriSalus Life Sciences Inc
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A